vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Ladder Capital Corp (LADR). Click either name above to swap in a different company.
Ladder Capital Corp is the larger business by last-quarter revenue ($22.3M vs $19.2M, roughly 1.2× Apyx Medical Corp). Ladder Capital Corp runs the higher net margin — 71.0% vs -6.8%, a 77.8% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -18.0%). Ladder Capital Corp produced more free cash flow last quarter ($78.7M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -22.5%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Ladder Capital Corp is a leading commercial real estate finance firm operating primarily across the United States. It originates and manages a diversified portfolio of senior secured commercial mortgage loans, mezzanine debt, commercial mortgage-backed securities, and direct real estate assets, serving property owners, operators and developers across major market segments.
APYX vs LADR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $22.3M |
| Net Profit | $-1.3M | $15.9M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 69.5% |
| Net Margin | -6.8% | 71.0% |
| Revenue YoY | 34.7% | -18.0% |
| Net Profit YoY | 71.9% | -49.4% |
| EPS (diluted) | — | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $22.3M | ||
| Q3 25 | $12.9M | $27.8M | ||
| Q2 25 | $11.4M | $21.5M | ||
| Q1 25 | $9.4M | $20.3M | ||
| Q4 24 | $14.2M | $27.2M | ||
| Q3 24 | $11.5M | $38.4M | ||
| Q2 24 | $12.1M | $34.3M | ||
| Q1 24 | $10.2M | $37.1M |
| Q4 25 | $-1.3M | $15.9M | ||
| Q3 25 | $-2.0M | $19.2M | ||
| Q2 25 | $-3.8M | $17.1M | ||
| Q1 25 | $-4.2M | $11.6M | ||
| Q4 24 | $-4.6M | $31.3M | ||
| Q3 24 | $-4.7M | $27.6M | ||
| Q2 24 | $-6.6M | $32.1M | ||
| Q1 24 | $-7.6M | $16.4M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 69.5% | ||
| Q3 25 | -6.5% | 72.4% | ||
| Q2 25 | -22.6% | 96.7% | ||
| Q1 25 | -32.4% | 52.7% | ||
| Q4 24 | -21.4% | — | ||
| Q3 24 | -31.6% | 74.1% | ||
| Q2 24 | -45.7% | 90.4% | ||
| Q1 24 | -64.6% | 49.4% |
| Q4 25 | -6.8% | 71.0% | ||
| Q3 25 | -15.4% | 69.0% | ||
| Q2 25 | -33.2% | 79.5% | ||
| Q1 25 | -44.0% | 56.8% | ||
| Q4 24 | -32.5% | 115.1% | ||
| Q3 24 | -40.9% | 71.7% | ||
| Q2 24 | -54.0% | 93.6% | ||
| Q1 24 | -74.0% | 44.2% |
| Q4 25 | — | $0.13 | ||
| Q3 25 | — | $0.15 | ||
| Q2 25 | — | $0.14 | ||
| Q1 25 | — | $0.09 | ||
| Q4 24 | — | $0.25 | ||
| Q3 24 | — | $0.22 | ||
| Q2 24 | $-0.19 | $0.26 | ||
| Q1 24 | $-0.22 | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $38.0M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $1.5B |
| Total Assets | $66.8M | $5.2B |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $38.0M | ||
| Q3 25 | $25.1M | $49.4M | ||
| Q2 25 | $29.3M | $134.9M | ||
| Q1 25 | $31.0M | $479.8M | ||
| Q4 24 | $31.7M | $1.3B | ||
| Q3 24 | $28.0M | $1.6B | ||
| Q2 24 | $32.7M | $1.2B | ||
| Q1 24 | $37.3M | $1.2B |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $1.5B | ||
| Q3 25 | $5.8M | $1.5B | ||
| Q2 25 | $7.3M | $1.5B | ||
| Q1 25 | $10.5M | $1.5B | ||
| Q4 24 | $14.2M | $1.5B | ||
| Q3 24 | $11.0M | $1.5B | ||
| Q2 24 | $14.7M | $1.5B | ||
| Q1 24 | $20.3M | $1.5B |
| Q4 25 | $66.8M | $5.2B | ||
| Q3 25 | $57.4M | $4.7B | ||
| Q2 25 | $58.2M | $4.5B | ||
| Q1 25 | $60.2M | $4.5B | ||
| Q4 24 | $64.8M | $4.8B | ||
| Q3 24 | $60.7M | $4.8B | ||
| Q2 24 | $65.4M | $4.8B | ||
| Q1 24 | $70.7M | $5.3B |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $87.0M |
| Free Cash FlowOCF − Capex | $-2.8M | $78.7M |
| FCF MarginFCF / Revenue | -14.6% | 352.4% |
| Capex IntensityCapex / Revenue | 1.4% | 37.4% |
| Cash ConversionOCF / Net Profit | — | 5.49× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $118.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $87.0M | ||
| Q3 25 | $-3.5M | $26.3M | ||
| Q2 25 | $-1.2M | $44.0M | ||
| Q1 25 | $-702.0K | $-28.7M | ||
| Q4 24 | $-2.9M | $133.9M | ||
| Q3 24 | $-4.4M | $169.0M | ||
| Q2 24 | $-4.3M | $45.4M | ||
| Q1 24 | $-6.3M | $-20.4M |
| Q4 25 | $-2.8M | $78.7M | ||
| Q3 25 | $-4.1M | $25.9M | ||
| Q2 25 | $-1.5M | $43.4M | ||
| Q1 25 | $-757.0K | $-29.6M | ||
| Q4 24 | $-3.2M | $127.4M | ||
| Q3 24 | $-4.6M | $166.0M | ||
| Q2 24 | $-4.6M | $44.9M | ||
| Q1 24 | $-6.4M | $-21.7M |
| Q4 25 | -14.6% | 352.4% | ||
| Q3 25 | -31.5% | 93.1% | ||
| Q2 25 | -13.2% | 201.6% | ||
| Q1 25 | -8.0% | -145.6% | ||
| Q4 24 | -22.4% | 468.2% | ||
| Q3 24 | -40.0% | 432.1% | ||
| Q2 24 | -38.0% | 131.0% | ||
| Q1 24 | -62.2% | -58.6% |
| Q4 25 | 1.4% | 37.4% | ||
| Q3 25 | 4.0% | 1.7% | ||
| Q2 25 | 2.3% | 2.9% | ||
| Q1 25 | 0.6% | 4.3% | ||
| Q4 24 | 1.7% | 23.9% | ||
| Q3 24 | 1.3% | 7.8% | ||
| Q2 24 | 2.4% | 1.3% | ||
| Q1 24 | 0.3% | 3.7% |
| Q4 25 | — | 5.49× | ||
| Q3 25 | — | 1.37× | ||
| Q2 25 | — | 2.57× | ||
| Q1 25 | — | -2.49× | ||
| Q4 24 | — | 4.27× | ||
| Q3 24 | — | 6.13× | ||
| Q2 24 | — | 1.41× | ||
| Q1 24 | — | -1.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
